Three-Month Experience With Tacrolimus Once-Daily Regimen in Stable Renal Allografts

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2323-2325

  Diez Ojea, B ^a   Alonso Alvarez M ^a   Aguado Fernandez S ^a   Banos Gallardo M ^b   Garcia Melendreras S ^b   Gomez Huertas E ^b  

^a HOSPITAL VALLE DEL NALÓN   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MR 4; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEINURIA;

ADMINISTRATION, ORAL; ADULT; AGED; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; SAFETY; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 68949207821     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.048     Document Type: Article

References (8)

1. Alloway R., Steinberg S., Khalil K., et al. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen. Transplant Proc 37 (2005) 867
2. Alloway R., Steinberg S., Khalil K., et al. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Transplantation 83 (2007) 1648
3. Florman S., Alloway R., Kalayoglu M., et al. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. Transplant Proc 37 (2005) 1211
4. Florman S., Alloway R., Kalayoglu M., et al. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Transplantation 83 (2007) 1639
5. Heffron T.G., Pescovitz M.D., Florman S., et al. Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant 7 (2007) 1609
6. First M.R., and Fitzsimmons W.E. Modified release tacrolimus. Yonsei Med J 45 (2004) 1127
7. Silva Jr. H.T., Yang H.C., Abouljoud M., et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 7 (2007) 595
8. Wente M.N., Sauer P., Mehrabi A., et al. Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation. Clin Transplant 20 S17 (2006) 80